Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib
出版年份 2021 全文链接
标题
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib
作者
关键词
Gene fusion, Health-related quality of life, Larotrectinib, NTRK, Quality of life, Tropomyosin receptor kinase
出版物
CURRENT PROBLEMS IN CANCER
Volume -, Issue -, Pages 100734
出版商
Elsevier BV
发表日期
2021-04-02
DOI
10.1016/j.currproblcancer.2021.100734
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 539P Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study
- (2020) A.P. Conley et al. ANNALS OF ONCOLOGY
- Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC
- (2019) Fabrice Barlesi et al. Journal of Thoracic Oncology
- Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial
- (2019) Sebastian Michels et al. Journal of Thoracic Oncology
- Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
- (2018) Marieke van Leeuwen et al. Health and Quality of Life Outcomes
- New Agents, Emerging Late Effects, and the Development of Precision Survivorship
- (2018) Eric J. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
- (2018) Theodore W Laetsch et al. LANCET ONCOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States
- (2018) S. Nolte et al. EUROPEAN JOURNAL OF CANCER
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
- (2017) Julie R Brahmer et al. LANCET ONCOLOGY
- Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients WithALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2
- (2016) Lucio Crinò et al. JOURNAL OF CLINICAL ONCOLOGY
- Current and Evolving Methods to Visualize Biological Data in Cancer Research
- (2016) Puey Ling Chia et al. JNCI-Journal of the National Cancer Institute
- Current and Evolving Methods to Visualize Biological Data in Cancer Research
- (2016) Puey Ling Chia et al. JNCI-Journal of the National Cancer Institute
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- (2013) Grace K. Dy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Early palliative care in cancer treatment: rationale, evidence and clinical implications
- (2013) Lynn Howie et al. Therapeutic Advances in Medical Oncology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007
- (2010) R. Sridhara et al. JNCI-Journal of the National Cancer Institute
- The Role of the U.S. Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
- (2010) A. E. McKee et al. ONCOLOGIST
- The PedsQL™ Infant Scales: feasibility, internal consistency reliability, and validity in healthy and ill infants
- (2010) James W. Varni et al. QUALITY OF LIFE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation